肝硬化常常并发脾功能亢进,表现为脾肿大,血小板、白细胞减少,少数患者红细胞也减少。对此,目前药物治疗效果欠佳。传统疗法为脾切除术。对于肝硬化患者,尤其肝功能代偿能力差者,这种手术的危险性增大,给原本已有损害的肝功能带来不良影响,重者可能诱发肝功能衰竭、严重感染和机体抵抗力下降。从70年代末起,国内外开始应用脾动脉栓塞术治疗脾功能亢进至今已三十余年,临床应用日趋增多,可获得肯定的近期和远期疗效。 方法:选择股动脉插管,在X线透视下行脾动脉造影,显示 Liver cirrhosis often complicated with hypersplenism, manifested as splenomegaly, thrombocytopenia, leukopenia, a small number of patients also reduce red blood cells. In this regard, the current poor drug treatment. Traditional therapy for splenectomy. For patients with liver cirrhosis, especially poor ability to compensate for liver dysfunction, the increased risk of such surgery, to the already had a detrimental impact on liver function, severe cases may induce liver failure, severe infection and body resistance decline. From the late 1970s, domestic and international began to apply splenic arterial embolization for hypersplenism has been more than 30 years, increasing clinical application, can obtain certain short-term and long-term efficacy. Methods: Select femoral artery catheterization, angiography under the spleen angiography, showed